Agata Majos1, Tomasz Wolak2, Piotr Bogorodzki3, Krzysztof Tybor4, Mariusz Heleniak4, Ludomir Stefaczyk5
1Radiology, Medical University of Lodz, Lodz, Poland; 2Institute of Physiology and Pathology of Hearing, Warsaw, Poland; 3Institute of Radioelectronics, Warsaw University of Technology, Warsaw, Poland; 4Neurosurgery, Medical University of Lodz, Lodz, Poland; 5Radiology, Medical Univerity of Lodz, Lodz, Poland
The aim - to determine the possibility to use T1 sequence with the administration of blood pool contrast agent (BPCA) in patients with brain tumors before and after operation.